Screening for hepatocellular carcinoma by Egyptian physicians

Table 2 Relation of the physicians’ age and knowledge of hepatocellular carcinoma epidemiology

	Age (yr)				P value
	< 45		≥45
	n	%	n	%
Recommended HCC surveillance
Chronic hepatitis B, C and liver cirrhosis	94	84	39	93	0.15
Positive family history	36	32	18	43	0.215
Everyone	19	17	3	7	0.121
Reduction of deaths from HCC by screening					0.419
< 30%	25	22	12	29
≥ 30%	87	787	30	71
Risk factors for liver disease progression
Age	49	448	14	33	0.242
Regular alcohol consumption	49	44	22	52	0.339
Gender	33	29	17	40	0.194
Obesity, DM	42	37	13	31	0.45
HCV genotype	54	48	32	76	0.002a
HBV-HCV co-infection	60	54	18	43	0.236
Leading cause of HCC in Egypt					0.11
HCV	93	83	30	71
HBV	19	17	12	29
Causes of death of HCC patients					0.096
Cancer	49	44	18	43
Liver failure	34	302	19	45
GI or variceal bleeding	29	25	5	12

^aP < 0.05 considered statistically significant. HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; HCV: Hepatitis C virus.